Lv1
10 积分 2022-06-01 加入
Characteristics of Carcinoembryonic Antigen-Related Cell Adhesion Molecules and Their Relationship to Cancer
2天前
已完结
IL-2-loaded Polypeptide Nanoparticles for Enhanced Anti-cancer Immunotherapy
2个月前
已完结
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
5个月前
已完结
Microenvironment-responsive anti-PD-L1 × CD3 bispecific T-cell engager for solid tumor immunotherapy
5个月前
已完结
An oncolytic virus–T cell chimera for cancer immunotherapy
6个月前
已完结
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
6个月前
已完结
Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma
7个月前
已完结
690P Ifinatamab deruxtecan (I-DXd; DS-7300) in patients with advanced solid tumors: Updated clinical and biomarker results from a phase I/II study
7个月前
已完结
Stepping forward in antibody-drug conjugate development
7个月前
已完结
Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management
7个月前
已完结
皖公网安备34019202002308
